Amberscript — Funding & Company Data
Financial overview and investor data for Amberscript.
Founded
2017
Stage
Series a
Total Raised
$10M
HQ
Amsterdam, Netherlands
Team
201-500
Model
sales-led
Analyst Take
Amberscript's funding trajectory indicates a deliberate, focused growth strategy rather than a hyper-growth, cash-burn approach. The company raised a single, significant Series A round of $10 million in late 2021, which is its only publicly verified funding event to date. The lack of subsequent funding rounds is not necessarily a negative signal; instead, it suggests a focus on achieving profitability and sustainable growth with the capital it has.
The quality of their lead investor, Endeit Capital, is noteworthy. Endeit is a reputable German-Dutch growth capital firm with a background in media, which aligns perfectly with Amberscript's core market. This strategic alignment is further evidenced by Endeit financing Amberscript's 2023 acquisitions of competitors abtipper.de and uitgetypt.nl, demonstrating the investor's continued commitment beyond the initial investment. This move points to a strategy of market consolidation and revenue acquisition over raising dilutive venture rounds.
From a competitive standpoint, Amberscript operates in a crowded AI transcription market with heavily-funded US competitors like Verbit and Otter.ai. However, Amberscript has carved out a strong niche in Europe by focusing on high accuracy for non-English languages, a key differentiator. The company's significant team growth, from 40 employees in 2021 to over 200 by early 2026, suggests that the Series A funding has been effectively deployed to scale operations and capture market share. For a potential user, this indicates a company that is growing sustainably and is deeply embedded in the European market, backed by strategic capital.
Stability
Amberscript appears to be a stable company. The nearly five-year runway since its last funding round, coupled with significant team growth and strategic acquisitions financed by its investor, suggests it is operating on a solid financial footing and is likely to be a reliable partner for the next 2+ years.
Growth
The company is on a clear growth trajectory, evidenced by a 5x increase in team size since its 2021 funding round and its strategy of acquiring competitors to consolidate its market leadership in the Netherlands and Germany.
For Buyers
For a potential buyer, Amberscript represents a relatively low-risk choice, particularly for European-based organizations. The company's stability, focus on non-US markets, and backing from a strategic investor suggest longevity and a commitment to its specific product niche.
Funding Timeline
Investors: Endeit Capital